STAT+: Here’s how Biden can address high drug prices, without help from Congress
WASHINGTON — If President Biden wants major pharmaceutical industry reforms, he may have to achieve them on his own.
That’s looking increasingly likely after the White House’s concession on Thursday that it is abandoning its push for Congress to include major drug pricing provisions in its long-debated social spending bill.
Continue to STAT+ to read the full story…
